Skip to main content
Caplight Logo









Eyebot

Eyebot

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://eyebot.co

Last Round

Series A

Aug 26, 2025

Total Funding Raised

$27.25M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Eyebot is a healthcare technology company that develops automated, self-serve vision testing kiosks designed to provide accessible eye prescriptions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Retail Technology, Telemedicine

Business Model

B2B2C

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

automated vision testingvision kiosktele-optometryretail health kioskeye exam kioskremote eye caredigital refractionprescription automationB2B2C healthtechoptical retail techself-service eye examdiagnostic kioskhealthtech hardware

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Eyebot Comparables

Compare Eyebot with similar companies based on industry and business-model similarity.

Eyebot comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GlobeChek
78%
Visibly
78%
DigitalOptometrics
78%

Eyebot Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AAug 26, 2025
SeedJun 6, 2024
Pre SeedSep 29, 2022

Key People

Founding team and executive leadership

Matthias Hofmann

Co-founder & CEO

Founding Team

Eyebot Investors

Notable investors and investment history

Eyebot investors
InvestorRounds
AlleyCorpSeries A, Seed
Global VillageSeed, Series A
Ravelin CapitalSeed
General CatalystSeries A
Village GlobalSeed, Pre Seed, Series A
Humba VenturesSeed, Series A
Spacecadet VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 1, 2026

    Automated vision testing technology pilot program launching December 1st, 2026.

  • Sep 13, 2026

    Monthly visitors grew 39% MoM, reaching 11.3K.

Recent news

Latest coverage and updates

  • launchesAug 20, 2026

    Eyebot launched automated vision test kiosk on Aug 20th '26.

  • partners_withAug 20, 2026

    Eyebot partnered with Quay on Aug 20th '26.

Eyebot Filings

Explore SEC and related filing metadata, where available.

Eyebot filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Eyebot's valuation, stock price, and market status.

Is Eyebot a public or private company?

Eyebot is a private company.

What is the current stock price of Eyebot?

Eyebot is a private company, so its shares have no public market price. Caplight tracks Eyebot's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Eyebot worth (valuation)?

Valuation information for Eyebot is not publicly available.

Can I buy Eyebot stock?

Eyebot shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Eyebot's last funding round?

Eyebot's most recent funding round was Series A on August 26, 2025.

Who are the main investors in Eyebot?

Key investors in Eyebot include AlleyCorp, General Catalyst, Ubiquity Ventures.

Will Eyebot IPO soon?

No public IPO plans have been announced for Eyebot.

How can I track Eyebot secondary market activity?

Caplight tracks bids, offers, and trades in Eyebot's shares on secondary markets.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range32
Year Founded2021
Last FundingAug 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?